Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes.

Wolfgang RathmannKlaus StrassburgerBrenda BongaertsPavel BobrovOliver KussKarsten MüssigDaniel F MarkgrafJulia SzendroediChristian HerderMichael Rodennull null

Published in: Diabetes, obesity & metabolism (2017)

Baseline hyperglycaemia is a strong predictor of requirement of early intensification of glucose-lowering therapy in newly diagnosed type 2 diabetes.

Keyphrases

newly diagnosed
type diabetes
glycemic control
blood glucose
cardiovascular disease
insulin resistance
metabolic syndrome
blood pressure
adipose tissue
skeletal muscle
weight loss